ESCAPE-NEXT Study
| Title: | A multicenter, randomized, double-blind, placebo-controlled, parallel group, single-dose design to determine the efficacy and safety of Nerinetide in patients with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. |
| Short summary: | ESCAPE-NEXT is designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. |
| Study design: | Multicenter, randomized, double-blind, placebo-controlled, parallel group, single-dose |
| Status: | ongoing |
| Local PI: | Prof. Marios-Nikos Psychogios, Head of diagnost. and interv. Neuroradiology |
| Link: |